#VisualAbstract: Pembrolizumab improves long-term survival in patients with stage III melanoma

byTeddy Guo

May 5, 2021

in StudyGraphics

Reading Time: 1 min read

Convalescent plasma transfusion provides mortality benefit in early COVID-19 disease stage

RelatedReports

StudyGraphics

#VisualAbstract: Dermatopathologists have varying perceptions on whether the overdiagnosis of different melanocytic skin lesions is a public health issue

April 28, 2022

StudyGraphics

#VisualAbstract: Neoadjuvant nivolumab plus chemotherapy increases event-free survival in resectable non-small-cell lung cancer

April 28, 2022

StudyGraphics

#VisualAbstract: Ruxolitinib use may be associated with higher incidences of nonmelanoma skin cancers

April 26, 2022

Oophorectomy associated with reduced cancer risk and all-cause mortality for BRCA1/2 patients

Oncology

Pembrolizumab did not show overall survival benefit in patients with microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer

April 18, 2022

Quick Take: Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent)

Sonelokimab 120 mg or less showed significant clinical benefit over placebo in patients with plaque psoriasis

#VisualAbstract: ChAdOx1 nCov-19 AstraZeneca COVID-19 vaccine not effective against B.1.351 variant

Addressing non-obesity related barriers may improve bariatric surgery effectiveness

Coronary microvascular dysfunction demonstrating improvement after surgery for inflammatory bowel disease

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Pembrolizumab improves long-term survival in patients with stage III melanoma

#VisualAbstract: Dermatopathologists have varying perceptions on whether the overdiagnosis of different melanocytic skin lesions is a public health issue

#VisualAbstract: Neoadjuvant nivolumab plus chemotherapy increases event-free survival in resectable non-small-cell lung cancer

#VisualAbstract: Ruxolitinib use may be associated with higher incidences of nonmelanoma skin cancers

Convalescent plasma transfusion provides mortality benefit in early COVID-19 disease stage

Sonelokimab 120 mg or less showed significant clinical benefit over placebo in patients with plaque psoriasis

RelatedReports

#VisualAbstract: Dermatopathologists have varying perceptions on whether the overdiagnosis of different melanocytic skin lesions is a public health issue

#VisualAbstract: Neoadjuvant nivolumab plus chemotherapy increases event-free survival in resectable non-small-cell lung cancer

#VisualAbstract: Ruxolitinib use may be associated with higher incidences of nonmelanoma skin cancers

Pembrolizumab did not show overall survival benefit in patients with microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer

Sonelokimab 120 mg or less showed significant clinical benefit over placebo in patients with plaque psoriasis

#VisualAbstract: ChAdOx1 nCov-19 AstraZeneca COVID-19 vaccine not effective against B.1.351 variant

Coronary microvascular dysfunction demonstrating improvement after surgery for inflammatory bowel disease

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

#VisualAbstract: Pembrolizumab improves long-term survival in patients with stage III melanoma

RELATED REPORTS

Convalescent plasma transfusion provides mortality benefit in early COVID-19 disease stage

Sonelokimab 120 mg or less showed significant clinical benefit over placebo in patients with plaque psoriasis

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports